FMP
Sonnet BioTherapeutics Holdings, Inc.
SONN
NASDAQ
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.
1.77 USD
0.02 (1.13%)
About
ceo
Dr. Pankaj Mohan Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.sonnetbio.com
exchange
NASDAQ
Description
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreeme...
CIK
0001106838
ISIN
US83548R3030
CUSIP
83548R105
Address
100 Overlook Center
Phone
609-375-2227
Country
US
Employee
12
IPO Date
Oct 31, 2006
Summary
CIK
0001106838
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
83548R105
ISIN
US83548R3030
Country
US
Price
1.77
Beta
1.12
Volume Avg.
102.27k
Market Cap
5.43M
Shares
-
52-Week
1.08-26.4
DCF
1.84
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.13
P/B
-
Website
https://www.sonnetbio.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest SONN News
It looks like there's no news available.
